Systematic review of the clinical and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer.

Mowatt, GZhu, SKilonzo, MBoachie, CFraser, CGriffiths, T R LN'Dow, JNabi, GCook, JVale, L2010-08-172010-08-172010-01Mowatt, G, Zhu, S, Kilonzo, M, Boachie, C, Fraser, C, Griffiths, T R L, N'Dow, J, Nabi, G, Cook, J & Vale, L 2010, 'Systematic review of the clinical and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer.', Health Technology Assessment, vol. 14, no. 4, pp. 1-353. https://doi.org/10.3310/hta140402046-4924aberdeen_publication: 16196ORCID: /0000-0001-5340-0081/work/162725338ORCID: /0000-0002-3450-4536/work/170010823http://hdl.handle.net/2164/7313533068182engSDG 3 - Good Health and Well-beingRC Internal medicineRCSystematic review of the clinical and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer.Journal article10.3310/hta14040144